Audrey Chang, Ph.D. will provide an overview of the services Minaris Advanced Testing offers to mAb, viral vaccine and advanced therapies providers – including biosafety testing, product characterization, viral clearance, stability studies, and analytical development.
Watch nowAbout the speaker
Audrey Chang, PhD
CMC Advisor at Minaris Advanced Testing
Dr Chang has over 28 years of government and industry experience in conducting biological product testing and in managing laboratories. Audrey earned her Ph.D. at the Johns Hopkins University in Biology, and after a post doc at the FDA, joined BioReliance where she held various positions of increasing responsibilities. Prior to joining Minaris Advanced Therapies, Audrey was VP of QC at Vigene BioSciences which was acquired by Charles River Laboratories. In her current role, Audrey provides technical solutions and support to clients for both traditional biologics and novel modalities. Audrey has always had a passion for driving innovative products to commercialization and is happy to bring her experience to the testing division at Minaris Advanced Therapies.